In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

DJ Pharma gets Cedax antibiotic from Schering-Plough

Executive Summary

In-licenser DJ Pharma has signed for the US marketing rights to Schering-Plough's Cedax (ceftibuten), a broad-spectrum oral cephalosporin antibiotic.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Marketing-Licensing
    • Reverse Licensing

Related Companies

UsernamePublicRestriction

Register